Table 4. OR for recurrence and mortality at 90 days in patients with ST72 MSSA compared to those with ST72 MRSA.
Analyses | Recurrence | Mortality | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | |
Univariate | 0.97 | 0.93–1.00 | 0.07 | 1.04 | 0.96–1.14 | 0.34 |
Multivariatea | 0.28 | 0.05–1.69 | 0.01 | 0.81 | 0.15–4.17 | 0.80 |
aMultivariate analyses were adjusted for age, sex, mode of acquisition, persistent bacteremia, underlying comorbidities, Charlson comorbidity index, predisposing conditions, focus of infection, metastatic infection, sepsis grade, Pitt bacteremia score, antibiotic resistance, duration of antibiotics, minimal inhibitory concentration by broth microdilution, agr dysfunction, and removal of infection focus.
OR, odds ratios; ST, sequence type; MRSA, methicillin-resistant Staphylococcus aureus; CI, confidence interval.